Nicotinamide: Necessary nutrient emerges as a novel cytoprotectant for the brain

Trends in Pharmacological Sciences

Volumn 24, Issue 5, 2003, Pages 228-232

  Maiese, Kenneth ^a   Chong, Zhao Zhong ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYSTEINE PROTEINASE; CYTOCHROME C; DNA; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLSERINE; PROTEIN KINASE B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG;

APOPTOSIS; BLOOD CLOTTING; BRAIN BLOOD VESSEL; BRAIN NERVE CELL; BRAIN PROTECTION; CELL DAMAGE; CELL ENERGY; CELL PH; CELL PROTECTION; CYTOLOGY; DOWNSTREAM PROCESSING; DRUG MECHANISM; ENERGY METABOLISM; ENZYME ACTIVITY; INFECTION PREVENTION; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOLECULAR DYNAMICS; NEUROPROTECTION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0038061606     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(03)00078-6     Document Type: Review

References (39)

1. Ishaque A., Al-Rubeai M. Role of vitamins in determining apoptosis and extent of suppression by bcl-2 during hybridoma cell culture. Apoptosis. 7:2002;231-239.
2. Lin S.-H., et al. Nicotinamide: a nutritional supplement that provides protection against neuronal and vascular injury. J. Med. Food. 4:2001;27-38.
3. Chong Z.Z., et al. Nicotinamide modulates mitochondrial membrane potential and cysteine protease activity during cerebral vascular endothelial cell injury. J. Vasc. Res. 39:2002;131-147.
4. Lin S.H., et al. Prevention of nitric oxide-induced neuronal injury through the modulation of independent pathways of programmed cell death. J. Cereb. Blood Flow Metab. 20:2000;1380-1391.
5. Crowley C.L., et al. The NAD+ precursors, nicotinic acid and nicotinamide protect cells against apoptosis induced by a multiple stress inducer, deoxycholate. Cell Death Differ. 7:2000;314-326.
6. Klaidman L.K., et al. Oxidative changes in brain pyridine nucleotides and neuroprotection using nicotinamide. Biochim. Biophys. Acta. 1525:2001;136-148.
7. Mokudai T., et al. Delayed treatment with nicotinamide (vitamin B3) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats. Stroke. 31:2000;1679-1685.
8. Maynard K.I., et al. Delayed multidose treatment with nicotinamide extends the degree and duration of neuroprotection by reducing infarction and improving behavioral scores up to two weeks following transient focal cerebral ischemia in Wistar rats. Ann. New York Acad. Sci. 939:2001;416-424.
9. Yang J., et al. Nicotinamide therapy protects against both necrosis and apoptosis in a stroke model. Pharmacol. Biochem. Behav. 73:2002;901.
10. Sakakibara Y., et al. Delayed treatment with nicotinamide (vitamin B3) reduces the infarct volume following focal cerebral ischemia in spontaneously hypertensive rats, diabetic and non-diabetic Fischer 344 rats. Brain Res. 931:2002;68-73.
11. Braun R.D., et al. Effects of the interaction between carbogen and nicotinamide on R3230 Ac tumor blood flow in Fischer 344 rats. Radiat. Res. 155:2001;724-733.
12. Hervias I., et al. 2-Deoxy-D-glucose prevents and nicotinamide potentiates 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity. J. Neurochem. 75:2000;982-990.
13. Maiese K., et al. Elucidating neuronal and vascular injury through the cytoprotective agent nicotinamide. Curr Med Chem-Imm, Endoc. & Metab. Agents. 1:2001;257-267.
14. Chong Z.Z., et al. Metabotropic glutamate receptors promote neuronal and vascular plasticity through novel intracellular pathways. Histol. Histopathol. 18:2003;173-189.
15. Zhang J., et al. Chemical hypoxia-ischemia induces apoptosis in cerebromicrovascular endothelial cells. Brain Res. 877:2000;134-140.
16. Shimohama S. Apoptosis in Alzheimer's disease - an update. Apoptosis. 5:2000;9-16.
17. El-Khodor B.F., et al. Ectopic expression of cell cycle markers in models of induced programmed cell death in dopamine neurons of the rat substantia nigra pars compacta. Exp. Neurol. 179:2003;17-27.
18. Fadok V.A., et al. Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J. Biol. Chem. 276:2001;1071-1077.
19. Maiese K., Vincent A.M. Membrane asymmetry and DNA degradation: functionally distinct determinants of neuronal programmed cell death. J. Neurosci. Res. 59:2000;568-580.
20. Dombroski D., et al. Phosphatidylserine expression on cell surfaces promotes antibody-dependent aggregation and thrombosis in beta2-glycoprotein I-immune mice. J. Autoimmun. 14:2000;221-229.
21. Jessel R., et al. Kinetics of apoptotic markers in exogenously induced apoptosis of EL4 cells. J. Cell Mol. Med. 6:2002;82-92.
22. Kiuchi K., et al. Nicotinamide prevents N-methyl-N-nitrosourea-induced photoreceptor cell apoptosis in Sprague-Dawley rats and C57BL mice. Exp. Eye Res. 74:2002;383-392.
23. Ungerstedt J.S., et al. Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin. Exp. Immunol. 131:2003;48-52.
24. Kops G.J., et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature. 419:2002;316-321.
25. Muir T., et al. Nicotinamide is cytoprotective against oxygen-glucose deprivation through protein kinase B and the transcription factor forkhead the modulation of a cascade of cysteine protease activity. Soc. Neurosci. Abstr. 32:2002;12.
26. Brookes P.S., et al. Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J. Biol. Chem. 275:2000;20474-20479.
27. Chong Z.Z., et al. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation. 106:2002;2973-2979.
28. Zhou H., et al. Akt regulates cell survival and apoptosis at a postmitochondrial level. J. Cell Biol. 151:2000;483-494.
29. Lemeshko S.V., Lemeshko V.V. Metabolically derived potential on the outer membrane of mitochondria: a computational model. Biophys. J. 79:2000;2785-2800.
30. Dumont E.A., et al. Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat. Med. 7:2001;1352-1355.
31. Tang D., et al. Caspase-8 activation and bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis. J. Biol. Chem. 275:2000;9303-9307.
32. Southan G.J., Szabo C. Poly(ADP-ribose) polymerase inhibitors. Curr. Med. Chem. 10:2003;321-340.
33. Burkle A. Physiology and pathophysiology of poly(ADP-ribosyl)ation. Bioessays. 23:2001;795-806.
34. Yang J., et al. The effects of nicotinamide on energy metabolism following transient focal cerebral ischemia in Wistar rats. Neurosci. Lett. 333:2002;91-94.
35. Hageman G.J., Stierum R.H. Niacin, poly(ADP-ribose) polymerase-1 and genomic stability. Mutat. Res. 475:2001;45-56.
36. Sheldon C., Church J. Intracellular pH response to anoxia in acutely dissociated adult rat hippocampal CA1 neurons. J. Neurophysiol. 87:2002;2209-2224.
37. Ko H.W., et al. Synergetic activation of p38 mitogen-activated protein kinase and caspase-3-like proteases for execution of calyculin A-induced apoptosis but not N-methyl-d-aspartate-induced necrosis in mouse cortical neurons. J. Neurochem. 74:2000;2455-2461.
38. Andreka P., et al. Cytoprotection by jun kinase during nitric oxide-induced cardiac myocyte apoptosis. Circ. Res. 88:2001;305-312.
39. Galan A., et al. Stimulation of p38 mitogen-activated protein kinase is an early regulatory event for the cadmium-induced apoptosis in human promonocytic cells. J. Biol. Chem. 275:2000;11418-11424.